Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 56 (10) , 1437-1452
- https://doi.org/10.1016/j.addr.2004.02.006
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Targeting of the photocytotoxic compound AlPcS4 to hela cells by transferrin conjugated peg‐liposomesInternational Journal of Cancer, 2002
- Mechanisms of transport of nucleosides and nucleoside analogues in choroid plexusAdvanced Drug Delivery Reviews, 1999
- Structural determinants of substrates and inhibitors: probing glutamate transporters with 2,4-methanopyrroldidine-2,4-dicarboxylateBioorganic & Medicinal Chemistry Letters, 1998
- Nucleoside and nucleobase transport systems of mammalian cellsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1996
- Membrane transport of nucleobases: Interaction with inhibitorsGeneral Pharmacology: The Vascular System, 1995
- Uptake and translocation of microparticles in small intestineDigestive Diseases and Sciences, 1995
- Substrate selectivity, potential sensitivity and stoichiometry of Na+-nucleoside transport in brush border membrane vesicles from human kidneyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1993
- Mechanisms of Intestinal Absorption of the Antibiotic, Fosfomycin, in Brush-Border Membrane Vesicles in Rabbits and Humans.Journal of Pharmacobio-Dynamics, 1992
- Lactate-proton cotransport in rabbit corneal epitheliumCurrent Eye Research, 1990
- Hypoglycemic effect of intestinally administered monosaccharide-modified insulin derivatives in rats.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990